131
Views
4
CrossRef citations to date
0
Altmetric
Research Reports

Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children’s Hospital Los Angeles/University of Southern California

, , , , , , & show all
Pages 400-403 | Received 16 Aug 2015, Accepted 25 Oct 2015, Published online: 02 Mar 2016

References

  • Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005;18:41–53.
  • Shields CL, Materin MA, Shields JA. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment. Arch Ophthalmol 2005;123:1610–1612.
  • Berry JL, Jubran R, Kim JW, et al. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer 2013;60:688–693.
  • Berry JL, Jubran R, Wong K, et al. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children’s Hospital Los Angeles experience. Br J Ophthalmol 2014;98:1061–1065.
  • Demirci H, Shields CL, Meadows AT, et al. Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol 2005;123:1525–1530.
  • Desjardins L, Chefchaouni MC, Lumbroso L, et al. Functional results after treatment of retinoblastoma. J AAPOS 2002;6:108–111.
  • Hall LS, Ceisler E, Abramson DH. Visual outcomes in children with bilateral retinoblastoma. J AAPOS 1999;3:138–142.
  • Kim JM, Kim JH, Kim SJ, et al. Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments. Korean J Ophthalmol 2010;24:347–352.
  • Lam BL, Judisch GF, Sobol WM, et al. Visual prognosis in macular retinoblastomas. Am J Ophthalmol 1990;110:229–232.
  • Migdal C. Bilateral retinoblastoma: the prognosis for vision. Br J Ophthalmol 1983;67:592–595.
  • Schefler AC, Cicciarelli N, Feuer W, et al. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology 2007;114:162–169.
  • Narang S, Mashayekhi A, Rudich D, et al. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma. Clin Experiment Ophthalmol 2012;40:736–742.
  • Gunduz K, Gunalp I, Yalcindag N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 2004;111:1917–1924.
  • Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657–664.
  • Berry J L, Jubran R, Lee T, et al. Low-dose chemoreduction for infants diagnosed with retinoblastoma before 6 months of age. Ocul Oncol Pathol 2015;1:103–110.
  • Greenwald MJ, Strauss LC. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 1996;103:1989–1997.
  • Mullaney PB, Abboud EB, Al-Mesfer SA. Retinal detachment associated with type III retinoblastoma regression after cryotherapy and external-beam radiotherapy. Am J Ophthalmol 1997;123:140–142.
  • Shields CL, Shields JA, DePotter P, et al. The effect of chemoreduction on retinoblastoma-induced retinal detachment. J Pediatr Ophthalmol Strabismus 1997;34:165–169.
  • Shields CL, Kaliki S, Shah SU, et al. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment. Retina 2012;32:799–804.
  • Palioura S, Gobin YP, Brodie SE, et al. Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment. Pediatr Blood Cancer 2012;59:859–864.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.